Lung-selective Cas13d-based nanotherapy inhibits lethal SARS-CoV-2 infection by targeting host protease Ctsl

Added 57 days ago (05.10.2021)
Authors: Cui, Z., Zeng, C., Huang, F., Yuan, F., Yan, J., Zhao, Y., Huang, J., Staats, H. F., Everitt, J. I., Sempowski, G. D., Wang, H., Dong, Y., Liu, S.-L., Wang, Q.
Source: bioRxiv
Read article